Down syndrome

¿Que es Down syndrome?

Down syndromees una de las afecciones genéticas más comunes y aproximadamente 1 de cada 700 bebés que nacen en los EE. UU. nace con esta síndrome.

Los investigadores aún no pueden identificar las razones exactas por las que se desarrolla el cromosoma adicional 21, y posiblemente haya varios factores en juego. Se cree que la edad materna es un factor de riesgo significativo, aunque más Down syndrome los bebés nacen de madres más jóvenes, eso se debe simplemente a que la tasa de natalidad entre las madres más jóvenes es más alta.

Condiciones de salud asociadas con Down syndrome incluyen hipotonía, enfermedades cardíacas y tiroideas, retrasos en el crecimiento físico, retrasos y trastornos intelectuales de leves a moderados y rasgos faciales muy característicos.

La hipotonía (tono muscular bajo), facies plana, fisuras palpebrales inclinadas hacia arriba, retraso en el desarrollo y pliegue único de la palma son algunos de los más frecuentes. Down syndrome caracteristicas.

Síndrome Sinónimos:
Down syndrome

¿Qué causan los cambios genéticos Down syndrome?

Down syndromees un trastorno genético. Es causado por la adición de una copia total o parcial del cromosoma 21. El síndrome también se conoce como trisomía 21. 95% de las personas diagnosticadas con Down syndrome Presentar trisomía 21, que es la forma más común de la condición genética. El 3% de las personas diagnosticadas tendrán el tipo de translocación y el 2% restante presentará mosaico. Down syndrome. No hay ningún elemento hereditario en la trisomía 21 y el mosaicismo. ⅓ de casos de Down syndrome resultantes de la translocación tienen un componente hereditario, que representa alrededor del 1% de todos los síndrome casos.

Genes, ubicaciones y modos de herencia
PRDX2, 19 p13. 13
MTHFR, 1 p36. 22
RCAN1, 21 q22. 12
NTF3, 12 p13. 31
VIP, 6 q25. 2
CTCF, 16 q22. 1
PRDX6, 1 q25. 1
CALCA, 11 p.15. 2
KANSL1, 17 q21. 31
DCAF7
EZH2, 7 p36. 1
RAD21, 8 q24. 11
NRAS, 1 p13. 2
S100B, 21 q22. 3
GATA1, Xp11. 23
SOD1, 21 q22. 11
STAG2, Xq25
GSTM2, 1 p13. 3
TP53, 17 p13. 1
SLC19A1, 21 q22. 3

Número OMIM - 190685 (consulte la página de OMIM para obtener información actualizada)

¿Cuales son los principales síntomas de Down syndrome?

El principal síntomas de Down syndrome incluyen rasgos faciales característicos como cara aplanada, especialmente en el puente de la nariz, ojos almendrados, cuello corto, orejas pequeñas y tono muscular pobre.

Los defectos cardíacos congénitos son una de las principales síntoma de Down syndromey otras condiciones de salud pueden incluir pérdida de audición, apnea obstructiva del sueño, infecciones del oído y enfermedades oculares.

Individuos con el síndrome puede ser diagnosticado con una discapacidad intelectual o cognitiva y retrasos en el desarrollo.

Posibles rasgos / características clínicas:
Falange media corta del 5 dedo, Hipotiroidismo, Estatura baja, Ala ilíaca hipoplásica, Epicanto, Aplanamiento malar, Deficiencia auditiva conductiva, Estenosis duodenal, Defecto completo del canal auriculoventricular, Microtia, Hipotonía muscular, Trastorno mieloproliferativo, Discapacidad intelectual, Macroglosia, Laxitud articular, Fisura palpebral inclinada hacia arriba, Cara plana, Lengua protuberante, Palma corta, Esporádica, Fosa acetabular poco profunda, Atresia anal, Enfermedad de Alzheimer, Megacolon agangliónico, Leucemia megacariocítica aguda, Inestabilidad atlantoaxial, Braquicefalia, Palma ancha, Manchas de Brushfield, Engrosamiento de la piel nucal , Pliegue palmar transversal único

Posibles rasgos / características clínicas:
Falange media corta del 5 dedo, Hipotiroidismo, Baja estatura, Ala ilíaca hipoplásica, Epicanto, Aplanamiento malar, Deficiencia auditiva conductiva, Estenosis duodenal, Defecto completo del canal auriculoventricular, Microtia, Hipotonía muscular, Trastorno mieloproliferativo, Discapacidad intelectual, Macroglosia, Laxitud articular, Fisura palpebral inclinada hacia arriba, Cara plana, Lengua protuberante, Palma corta, Esporádica, Fosa acetabular poco profunda, Atresia anal, Enfermedad de Alzheimer, Megacolon agangliónico, Leucemia megacariocítica aguda, Inestabilidad atlantoaxial, Braquicefalia, Palma ancha, Manchas de Brushfield, Engrosamiento de la piel nucal , Pliegue palmar transversal único

¿Cómo se hace la prueba a alguien? Down syndrome?

Detección y prueba de Down syndrome puede comenzar prenatalmente. Los exámenes prenatales estiman las posibilidades de que el feto tenga Down syndrome mientras que las pruebas de diagnóstico pueden proporcionar un diagnóstico definitivo con una tasa de precisión muy alta.

Después del nacimiento, el diagnóstico inicial de Down syndrome puede comenzar con la detección del análisis facial, a través de la FDNA Telehealth plataforma de telegenética, que puede identificar los marcadores clave de la síndrome y describa la necesidad de realizar más pruebas. Seguirá una consulta con un asesor genético y luego con un genetista. 

Sobre la base de esta consulta clínica con un genetista, se compartirán las diferentes opciones para las pruebas genéticas y se buscará el consentimiento para realizar más pruebas.

Información médica sobre Down syndrome

Cognitive impairment, muscle hypotonia at birth, and dysmorphic features occur to some extent in all individuals with Down syndrome (DS). In addition, various anomalies of the respiratory, cardiovascular, gastrointestinal, hematological, immune, endocrine, musculoskeletal, renal and genitourinary systems, and sensory organs, are often associated with DS, as well as psychiatric disorders (Arumugam, 2016). The syndrome is characterized by extensive phenotypic variability; most of the mentioned anomalies occur in only a fraction of affected individuals.

In 1866, John Langdon Down first described a set of characteristics of the disorder that is now referred to as DS. In 1959, Jerome Lejeune discovered that an extra copy of chromosome 21 caused the condition.

While intellectual disability is ubiquitous in DS, there is a wide range of variation in cognitive performance (Lot, 2012; Couzens et al., 2011; Tsao and Kindelberger, 2009). Weakness in language abilities has been noted in all children with DS (Dykens et al., 2006; Fidler et al., 2005; Rondal et al., 2003). But even here, there is performance improvement with age as noted in lexical store, comprehension of interpersonal relations, and visual motor processing. Socialization and competence in daily living skills appear to improve through age 30 years in DS (Dressler et al., 2010). Children with DS appear to present memory profiles that are distinct from Williams and fragile-X syndromes in that DS is characterized by good immediate visual memory and rapid phonological retrieval with poor verbal working memory skills (Conners et al., 2011; Edgin et al., 2010b).

A modern understanding of neurocognitive function in DS was established by Nadel (1986), who suggested that intellectual disabilities gradually arose in early childhood from developmental arrest of late-maturing brain structures, including the prefrontal cortex, hippocampus, and cerebellum. Incomplete development of the prefrontal cortex, hippocampus, and cerebellum has a variety of effects on DS cognition (reviewed by Fernandex et al., 2015). The impairment of the prefrontal cortex in DS precludes real-world abilities to creatively troubleshoot and overcome problems.

Consistent with the underdevelopment of the hippocampus, individuals with DS are impaired in verbal and nonverbal assessments of intermediate or long-term memory. Also in accordance with hippocampal abnormalities, teenagers and adults with DS have trouble navigating in real environments when forced to use geometric and layout information (Edgin et al., 2012).

Overt structural pathology in the cerebellum of DS patients causes difficulties with gross motor coordination; however, these difficulties are nuanced (Baxter et al., 2000; Aylward et al., 1997). Older children and adults with DS display atypical patterns of movement and problems with handwriting and other tasks that require use of fine digits (Galli et al., 2010; Latash et al., 2002).

Researchers have charted IQ declines in children with DS that begin around the time toddlers learn to walk (Fernandex et al., 2015). Cognition deteriorates to varying degrees in typically developing DS individuals as they enter advanced age, despite moderate compensation through the posterior-anterior shift (Davis et al., 2008).

Infants and toddlers born with trisomy 21 start life with deficits in mastery motivation, an intrinsic quality that compels very young children to explore and gain control over the surrounding environment (Niccols et al., 2003). Deficits in mastery motivation cripple the emergence of instrumental learning in those with DS (Fidler, 2006; Fidler et al. 2005). Infants with DS take longer than chronological age-matched controls to move from shorter chains of continuous goal-directed behaviors to longer chains and are less happy when performing more complex chain-linking (Ruskin et al., 1994; Dunst 1988). Gradually, motivational issues exacerbate the cognitive disabilities that arise from poor brain development (Cicchetti and Sroufe 1976).

Individuals with DS participate in special education or mainstream schooling. Despite efforts to the contrary, they are exposed to significant cognitive difficulties in these settings that will end in only some limited success and skills achievement. Less-than-favorable learning histories and dependence on caregivers might create the impression of diminishing returns on further educational activities. The result is seclusion from peers and negative self-perceptions that prime feelings of inadequacy and depression (Ali et al., 2012; Capone et al., 2006; Fidler et al., 2005, 2006; Dykens et al., 2002).

Children with DS are predominantly brachycephalic (62.3%), but they can also be hyperbrachycephalic (27.3%), dolichocephalic (7.8%), or mesocephalic (2.6%). In a retrospective analysis of 524 individuals with DS, more than 50% had craniofacial defects such as a downward slant of the eye lids medially (83.9%), ear anomalies (66.9%), palpebronasal (epicanthal) folds (56.9%), and a flat face (50.9%) (Kava et al., 2004). In addition, hypertelorism (increased interocular distance) and a flat nasal bridge appear to be predominant in this population (Rahul et al., 2015).

The oral dysmorphic features common among people with DS are a fissured tongue and a high arched palate (Rahul et al., 2015; Shukla et al., 2014). In addition to these two traits (each with a prevalence of 79%), a recent epidemiological survey of children with DS (n=570) in India noted other oral manifestations such as macroglossia (83%), marginal gingivitis (93%), microdontia (63%), hypodontia (41%), an anterior open bite (23%) and periodontitis (11.5%) (Rahul et al., 2015). In addition, other aberrant oral conditions such as malocclusion (between 3% and 55%), congenital absence of teeth (34%), delayed teeth eruption (10%), angular cheilitis (22%), and ankyloglossia (13%) have also been reported in children with DS (Shukla et al., 2014).

Abnormalities of the musculoskeletal system have frequently been reported in the literature and mostly relate to ligament laxity, a distinctive feature of DS. In the cervical spine region, ligament laxity can give rise to occipitocervical instability and atlantoaxial instability (AAI). About 10-35% of patients with DS are affected by AAI (Cremers et al., 1993; Roy et al., 1990; Alvarez and Rubin, 1986) but only 1-2% present with cervical myelopathy (Hankinson and Anderson, 2010; Pueschel et al., 1987; Pueschel et al., 1984). In addition, os odontoideum (separation of a portion of the dens from the body of the axis [C2]) (Semine et al., 1978), hypoplasia of the atlas (Matsunaga et al., 2007; Taggard et al., 2000), bifid atlantal arches (Menezes, 2008) or ossiculum terminale (congenital non-union of the dens from a terminal ossicle located above the transverse ligament) (Ali et al., 2006) can coexist in DS.

Other musculoskeletal abnormalities include dislocation/subluxation of the patella, deformities such as genu valgum, pes planus, metatarsus primus varus, and scoliosis (Yam et al., 2008; Diamond et al., 1981), all of which have been attributed to ligament laxity (Galli et al., 2014). In addition, brachycephaly, brachydactyly, wide hands, fifth finger clinodactyly, increased web space between the great and second toes, and short stature have been documented as possible morphological changes (Roizen and Patterson, 2003).

The most common reasons for hospitalization of children with DS are respiratory disorders (predominantly because of infection) and congenital heart malformations (Englund et al., 2013; Fitzgerald et al., 2013). Common respiratory problems include upper respiratory tract anomalies, recurrent aspiration, obstructive sleep apnea and recurrent respiratory tract infections (Pandit and Fitzgerald, 2012).

Obstructive sleep apnea is the most common respiratory disorder, occurring in 30-50% of individuals with DS (Lal et al., 2015). It can be associated with a narrowed airway, enlarged tonsils and adenoids, macroglossia, mid-face hypoplasia, delayed development of oromotor function, and micrognathia (Goffinski et al., 2015; Austeng et al., 2014). Children with DS can present with obstructive airway disease caused by macroglossia, a constricted nasopharynx, congenital subglottic stenosis, laryngomalacia ('malacia' denotes any abnormal softening of the tissues), tracheobronchomalacia, and tracheal stenosis (Pravit, 2014; Jacobs et al., 1996).

The congenital cardiac disorders most commonly associated with DS are atrioventricular defects (45%) and ventricular septal defects (VSD) (35%), while abnormalities such as isolated secundum atrial septal defects (8%), isolated tetralogy of Fallot (4%) and isolated patent ductus arteriosus are less frequent (Freeman et al., 1998). The major complication of cardiac anomalies in DS is pulmonary artery hypertension, which can progress to cardiogenic shock and eventually death (de Rubens Figueroa et al., 2003).

Incidence of cardiovascular abnormalities in a DS population was estimated as 42% in a study in the United Kingdom (Irving and Chaudhari, 2012), while the prevalence of congenital cardiac diseases ranged between 40% and 76% depending on the cohort studied (Paladini et al., 2000). The chromosome 21 aneuploidy can result in endocardial cushion defects (complete or incomplete) (Ferencz et al., 1989).

Ear problems such as inner ear dysplasia/hypoplasia, vestibular malformations, lateral semicircular anomalies, and conductive, mixed or neurosensory hearing loss are common in patients with DS (Blaser et al., 2006). Moreover, a high prevalence of chronic otitis media with effusion (60%) has also been reported (Maris et al., 2014).

Vision problems evident in DS include severe refractive errors (50%) and cataracts (15%) (Bull, 2011). In addition, strabismus (47%), nasolacrimal duct obstruction (36%), and nystagmus (16%) have been reported (Stephen et al., 2007). Other ophthalmic conditions such as retinal hemorrhage and macular hypoplasia are rare among affected children (Stephen et al., 2007).

Gastrointestinal defects such as duodenal stenosis/atresia (3.9%), anal stenosis/atresia (1.0%), Hirschsprung disease (0.8%), esophageal atresia with or without tracheoesophageal fistula (0.4%), and pyloric stenosis (0.3%) (Freeman et al., 2009) have been reported (overall frequency 7%). The prevalence of celiac disease in DS is about 5% in Italian patients, manifesting in classical form with diarrhea and vomiting (65%), a silent form (20%), or with atypical symptoms such as short stature/anemia (11%) (Bonamico et al., 2001).

Abnormalities of the immune system have been associated with DS (Kusters et al., 2009). Moreover, increased incidences of leukemia, hypothyroidism, malnutrition (zinc deficiency), celiac disease and diabetes mellitus in children with DS aggravate their immune deficiency (Ram and Chinen, 2011). Leukemia is estimated to be 15 to 20 times more frequent in children with DS (Whitlock, 2006). DS is an independent risk factor for the development of both acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) (Lange, 2000). ALL in DS is characterized by unique clinical features that include heightened sensitivity to methotrexate and an increased propensity to infections (Whitlock, 2006).

Thyroid dysfunction is the most common endocrine abnormality in patients with DS (Iughetti et al., 2014; Hawli et al., 2009). Estimates of its prevalence vary widely, ranging between 3% and 54% in adults (Hawli et al., 2009). In one study, the frequency of hypothyroidism in neonates with DS was estimated to be 28 times higher than expected in the general population (Purdy et al., 2014).

Renal and urinary tract malformations were found in 3.2% of DS patients in the retrospective cohort study by Kupferman et al. (2009). They reported a high risk of cystic dysplastic kidney, renal agenesis, hydronephrosis, anterior urethral obstruction, and anterior urethral obstruction in this population. Other urogenital anomalies such as cryptorchidism (undescended or maldescended testes), bladder exstrophy, posterior urethral valves, hypospadias (urethral opening on the inferior aspect of the penis), testicular microlithiasis, testicular malignancy, and infertility have also been noted in DS (Ebert et al., 2008; Vachon et al., 2006; Mercer et al., 2004). A review of the literature by Mercer et al. (2004) reported renal hypoplasia, glomerular microcysts, and obstructive uropathy as the most common urological abnormalities in DS.

The prevalence of psychiatric disorders in DS ranges between 22.1% and 38% (Dykens et al., 2015). Some risk factors associated with psychiatric disorders in DS are age, gender, serotonin dysfunction, sleep problems, life stressors, hypothyroidism, cardiac surgery, obesity, mosaicism, family genetics, personality, and strength (Dykens, 2007). Recently, high rates of psychosis and depression have been reported among young adults and adolescents with DS (Dykens et al., 2015; Zigman, 2013; Collacott et al., 1992). Other psychopathologies noted in adults with DS include phobias, obsessive-compulsive disorders, anorexia nervosa and other eating disorders, Tourette syndrome, and paraphilias (aberrant sexual desires) (Dykens et al., 2015).

Weisfeld-Adams and colleagues (2016) described a patient with a de novo 2.78-Mb duplication on chromosome 21q22.11 including 16 genes. The patient was born to a 36-year-old mother diagnosed with high risk for Down syndrome on prenatal biochemical screening. At five years of age, some facial features were compatible to features typical to Down syndrome, including a round, flat face with upslanting palpebral fissures, prominent epicanthal folds, flat nasal bridge, and mild macroglossia. Hands were small with bilateral fifth finger clinodactyly and bilateral single transverse palmar creases; the feet showed a wide gap between the first and second toes. The girl had mild developmental delay.

* This information is courtesy of the L M D.
If you find a mistake or would like to contribute additional information, please email us at: [email protected]

¡Obtenga un Diagnóstico Genético más rápido y preciso!

Más de 250,000 pacientes analizados con éxito.
No espere años para recibir un diagnóstico. Actúe ahora y ahorre un tiempo valioso.

¡Empieza aqui!

"Nuestro camino hacia el diagnóstico de una enfermedad rara fue un viaje de 5 años que solo puedo describir como intentar hacer un viaje por carretera sin mapa. No sabíamos nuestro punto de partida. No sabíamos nuestro destino. Ahora tenemos esperanza ".

Imagen

Paula y Bobby
Padres de Lillie

¿Qué es FDNA Telehealth?

FDNA Telehealth es una empresa líder en salud digital que brinda un acceso más rápido a análisis genéticos precisos.

Con una tecnología hospitalaria recomendada por genetistas líderes, nuestra plataforma única conecta a los pacientes con expertos en genética para responder a sus preguntas más urgentes y aclarar cualquier inquietud que puedan tener sobre sus Síntomas.

Beneficios de FDNA Telehealth

Icono de FDNA

Credibility

Actualmente, nuestra plataforma la utilizan más del 70% de los genetistas y se ha utilizado para diagnosticar a más de 250,000 pacientes en todo el mundo.

Icono de FDNA

Accesibilidad

FDNA Telehealth ofrece análisis y exámenes faciales en minutos, seguidos de un acceso rápido a consejeros genéticos y genetistas.

Icono de FDNA

Facilidad de uso

Nuestro proceso comienza con un diagnóstico inicial en línea por parte de un consejero genético y sigue con consultas con genetistas y pruebas genéticas.

Icono de FDNA

Exactitud y precisión

Capacidades y tecnología de inteligencia artificial (IA) avanzadas con una tasa de precisión del 90% para un análisis genético más preciso.

Icono de FDNA

Valor por
Dinero

Acceso más rápido a consejeros genéticos, genetistas, pruebas genéticas y un diagnóstico. Tan rápido como en 24 horas si es necesario. Ahorre tiempo y dinero.

Icono de FDNA

Privacidad y seguridad

Garantizamos la máxima protección de todas las imágenes e información del paciente. Sus datos siempre están seguros, protegidos y encriptados.

Con FDNA Telehealth, se puede acercar a un diagnóstico.
¡Reserve ya su hora para la sesión de asesoramiento genético en línea, dentro de 72 horas!

EspañolDeutschPortuguêsFrançaisEnglish